Literature DB >> 10503925

Regulation of osteoclast activity.

E M Greenfield1, Y Bi, A Miyauchi.   

Abstract

Osteoclasts are the primary cell type responsible for bone resorption. This paper reviews many of the known regulators of osteoclast activity, including hormones, cytokines, ions, and arachidonic acid metabolites. Most of the hormones and cytokines that inhibit osteoclast activity act directly on the osteoclasts. In contrast, most of the hormones and cytokines that stimulate osteoclast activity act indirectly through osteoblasts. Particularly interesting in this regard are agents that directly inhibit activity of highly purified osteoclasts yet stimulate activity of osteoclasts that are co-cultured with osteoblasts. Recent studies have demonstrated that the primary mechanism by which bone resorptive agents stimulate osteoclast activity indirectly is likely to be up-regulation of production of osteoclast differentiation factor/osteoprotegerin ligand (ODF/OPGL) by the osteoblasts. In addition to discussing regulators of osteoclast activity per se, this paper also reviews the role of osteoclast apoptosis to limit the extent of bone resorption.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10503925     DOI: 10.1016/s0024-3205(99)00156-3

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Does sodium fluoride in bone cement affect implant fixation. Part II: evaluation of the effect of sodium fluoride additions to acrylic bone cement and the fixation of titanium implants in ovariectomized rabbits.

Authors:  Mikael Sundfeldt; Jan Persson; Janos Swanpalmer; Ann Wennerberg; Johan Kärrholm; Carina B Johansson; Lars V Carlsson
Journal:  J Mater Sci Mater Med       Date:  2002-11       Impact factor: 3.896

2.  Vascular analysis as a proxy for mechanostransduction response in an isogenic, irradiated murine model of mandibular distraction osteogenesis.

Authors:  Sagar S Deshpande; Alexis Donneys; Stephen Y Kang; Erin E Page; Peter A Felice; Lauren Kiryakoza; Noah S Nelson; Jose Rodriguez; Samir S Deshpande; Steven R Buchman
Journal:  Microvasc Res       Date:  2014-08-27       Impact factor: 3.514

3.  Substantial elevation of interleukin-6 concentration in peritendinous tissue, in contrast to muscle, following prolonged exercise in humans.

Authors:  Henning Langberg; Jens L Olesen; Carsten Gemmer; Michael Kjaer
Journal:  J Physiol       Date:  2002-08-01       Impact factor: 5.182

Review 4.  Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy--PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects.

Authors:  Marino Muxfeldt Bianchin; Heraldo M Capella; Daniel Loureiro Chaves; Mário Steindel; Edmundo C Grisard; Gerson Gandi Ganev; João Péricles da Silva Júnior; Schaeffer Neto Evaldo; Mônica Aparecida Poffo; Roger Walz; Carlos G Carlotti Júnior; Américo C Sakamoto
Journal:  Cell Mol Neurobiol       Date:  2004-02       Impact factor: 5.046

Review 5.  Reconciling the effects of inflammatory cytokines on mesenchymal cell osteogenic differentiation.

Authors:  Sagar Deshpande; Aaron W James; Jordan Blough; Alexis Donneys; Stewart C Wang; Paul S Cederna; Steven R Buchman; Benjamin Levi
Journal:  J Surg Res       Date:  2013-08-06       Impact factor: 2.192

6.  Dexamethasone inhibits bone resorption by indirectly inducing apoptosis of the bone-resorbing osteoclasts via the action of osteoblastic cells.

Authors:  S Warabi; Y Tachibana; M Kumegawa; Y Hakeda
Journal:  Cytotechnology       Date:  2001-01       Impact factor: 2.058

7.  In vivo assessment of the host reactions to the biodegradation of the two novel magnesium alloys ZEK100 and AX30 in an animal model.

Authors:  Tim Andreas Huehnerschulte; Janin Reifenrath; Brigitte von Rechenberg; Dina Dziuba; Jan Marten Seitz; Dirk Bormann; Henning Windhagen; Andrea Meyer-Lindenberg
Journal:  Biomed Eng Online       Date:  2012-03-20       Impact factor: 2.819

Review 8.  Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone.

Authors:  Marlous Rotman; Neveen Agnes Therese Hamdy; Natasha M Appelman-Dijkstra
Journal:  Br J Clin Pharmacol       Date:  2018-12-25       Impact factor: 4.335

9.  Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway.

Authors:  Wei Liu; Chao Xu; Hongyan Zhao; Pengpeng Xia; Ruilong Song; Jianhong Gu; Xuezhong Liu; Jianchun Bian; Yan Yuan; Zongping Liu
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.